JOINT FILING AGREEMENTJoint Filing Agreement • August 6th, 2013 • Celgene European Investment Co LLC • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of stock of Agios Pharmaceuticals, Inc.
AGIOS PHARMACEUTICALS, INC. SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT Dated as of April 14, 2010Series B Convertible Preferred Stock Purchase Agreement • August 6th, 2013 • Celgene European Investment Co LLC • Pharmaceutical preparations • Delaware
This Agreement (“Agreement”) dated as of April 14, 2010 is entered into by and among Agios Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Celgene Corporation, a Delaware corporation (the “Purchaser”).
AGIOS PHARMACEUTICALS, INC. SERIES C-1 CONVERTIBLE PREFERRED STOCK AND SERIES C-2 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT Dated as of November 16, 2011Series C-1 and C-2 Convertible Preferred Stock Purchase Agreement • August 6th, 2013 • Celgene European Investment Co LLC • Pharmaceutical preparations • Delaware
This Agreement (“Agreement”) dated as of November 16, 2011 is entered into by and among Agios Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the individuals and entities listed on Exhibit A hereto (the “Purchasers”).
